Société Tunisienne des Maladies Respiratoires et d'Allergologie STMRA - Infection and mRNA vaccine-induced immunity may be retained against SARS-CoV-2 variant B.1.1.7

Sté Tunisienne des Maladies Respiratoires et d'Allergologie

Cercle des Bureaux - Appartement B 5-3 . 1082 Centre urbain Nord Tunis

Infection and mRNA vaccine-induced immunity may be retained against SARS-CoV-2 variant B.1.1.7

Infection and mRNA vaccine-induced immunity may be retained against SARS-CoV-2 variant B.1.1.7

Zouhair Souissi

Bibliographie

22 mars 2021

Neutralizing Antibodies Against SARS-CoV-2 Variants After Infection and Vaccination – JAMA

The post Infection and mRNA vaccine-induced immunity may be retained against SARS-CoV-2 variant B.1.1.7 appeared first on Links Medicus.

Lu 616 fois

Taille de police Réduire la taille de la police Augmenter la taille de police

Évaluer cet élément

1
2
3
4
5

(0 Votes)

Plus dans cette catégorie : « Expert consensus statements for the management of COVID-19-related acute respiratory failure SARS-CoV-2 variants B.1.351 and P.1 can escape from therapeutic antibodies and evade antibodies induced by infection or mRNA vaccination »

About Author

Zouhair Souissi

Dernier de Zouhair Souissi

Recherche